EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments

EyePoint Pharmaceuticals (EYPT) Misses Q4 EPS by 55c

March 2, 2023 7:37 AM EST

EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q4 EPS of ($1.16), $0.55 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $10.4 million.

For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.

... More